CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $83,000 | -1.2% | 14,351 | +21.1% | 0.01% | -14.3% |
Q1 2021 | $84,000 | -1.2% | 11,851 | -18.8% | 0.01% | -12.5% |
Q3 2020 | $85,000 | +9.0% | 14,591 | +25.9% | 0.01% | 0.0% |
Q2 2020 | $78,000 | -10.3% | 11,591 | -14.8% | 0.01% | -33.3% |
Q1 2020 | $87,000 | -56.9% | 13,601 | +205.9% | 0.01% | -40.0% |
Q2 2018 | $202,000 | -47.1% | 4,446 | -38.5% | 0.02% | -50.0% |
Q1 2018 | $382,000 | -12.0% | 7,226 | +13.3% | 0.04% | -28.6% |
Q4 2017 | $434,000 | +7.4% | 6,376 | +30.1% | 0.06% | +5.7% |
Q3 2017 | $404,000 | +2.0% | 4,900 | +16.0% | 0.05% | +1.9% |
Q2 2017 | $396,000 | +76.8% | 4,225 | +19.9% | 0.05% | +79.3% |
Q1 2017 | $224,000 | – | 3,525 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |